PRE Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-3.630.0% YoY
Profit margin-42.0%HEALTHCARE
Market cap$341.7MSmall cap

Wall Street coverage

$31.00median target· current $6.09 (+409.0%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
PEG ratio
0.00
P/B
2.89
P/S (TTM)
2.85
EV/EBITDA
0.14

Profitability & growth

ROE (TTM)
-40.8%
Operating margin
-24.7%
Revenue growth YoY
107.7%
Dividend yield
Beta
0.24
Last earnings
Jun 10, 2026 · Estimate $-0.49 · Reported $-0.56
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Prenetics Global Ltd

Prenetics Global Ltd (PRE) is a pioneering health technology company that specializes in cutting-edge genetic and diagnostic testing solutions, providing critical health insights to both consumers and healthcare professionals. With a strong emphasis on research and development, Prenetics has established a significant international presence through strategic partnerships and collaborations. As a leader in personalized medicine, the company is well-positioned to capitalize on the increasing demand for accessible and actionable health data, presenting a compelling investment opportunity in the…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
UNIT 703-706, K11 ATELIER KING?S ROAD, QUARRY BAY
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$341.7M
Shares outstanding$15.4M
52W high$23.63
52W low$7.17

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer